cd 437 has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhagyaraj, E; Gupta, P; Gupta, R; Kalra, R; Khatri, N; Mahajan, S; Nanduri, R; Saini, A | 1 |
| Farso, MC; Krantic, S; Quirion, R; Rubio, M; Sarfati, M | 1 |
2 other study(ies) available for cd 437 and Inflammation
| Article | Year |
|---|---|
An Accord of Nuclear Receptor Expression in CD4
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Arthritis, Experimental; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; Collagen Type II; Cytokines; Female; Humans; Inflammation; Male; Mice; Mice, Inbred DBA; Phenylacetates; Receptors, Cytoplasmic and Nuclear; Retinoids; Synovial Fluid; Thiazoles; Thiosemicarbazones; Transcription, Genetic | 2019 |
The retinoid, 6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid, controls proliferative, morphological, and inflammatory responses involved in microglial activation without cytotoxic effects.
Topics: Animals; Blotting, Western; Cell Proliferation; Cell Separation; Flow Cytometry; Immunohistochemistry; Inflammation; Inflammation Mediators; Microglia; Rats; Rats, Sprague-Dawley; Retinoids; Signal Transduction | 2011 |